Pfizer planning to increase Indian activity
Pfizer has indicated that it is planning to increase its activity in India as it searches for new revenue streams and operating efficiencies.
Archives for March 25, 2008
Heparin recall widens in US
The heparin recall has widened after a lot of heparin sodium USP active pharmaceutical ingredient (API) produced by Scientific Protein Laboratories (SPL) was found to contain a heparin-like contaminant.
Pharmaceutical contract services round-up
Outsourcing-Pharma compiles the latest in motley pharma services news, including PRA International, Odyssey Logistics and Kuehne+Nagel.
Toyama acquisition shows Fujifilm's pharma ambitions
Japan's Fujifilm Holdings has taken a definitive sidestep into pharmaceuticals after completing a tender offer that gives the camera, photography and information solutions specialist a share stake representing 67.42 per cent of the voting rights of...
Customer recalls product using Cambrex API
Cambrex Corp, the US-based manufacturer of small-molecule active pharmaceutical ingredients (APIs) and advanced intermediates for the drug industry, has announced that one of its customers is recalling a product for which Cambrex currently supplies...
Expression Analysis buys novel DNA sequencing technology
Genomic services firm Expression Analysis has purchased the first-ever commercially-available technology to allow the sequencing of a single molecule of DNA, without amplification.
Product News in Brief
Varian, Invitrogen, BMG Labtech and Hosokawa Micron have all recently announced new product launches, detailing a selection of tools and equipment to aid the scientist working in the laboratory environment.